Cover Image

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Structured and harmonized implementation of molecular tumor boards (MTB) for the clinical interpretation of molecular data presents a current challenge for precision oncology. Heterogeneity in the interpretation of molecular data was shown for patients even with a limited number of molecular alterat...

Full description

Saved in:
Bibliographic Details
Main Authors: Rieke, Damian (Author) , de Bortoli, Till (Author) , Horak, Peter (Author) , Lamping, Mario (Author) , Benary, Manuela (Author) , Jelas, Ivan (Author) , Rüter, Gina (Author) , Berger, Johannes (Author) , Zettwitz, Marit (Author) , Kagelmann, Niklas (Author) , Kind, Andreas (Author) , Fabian, Falk (Author) , Beule, Dieter (Author) , Glimm, Hanno (Author) , Brors, Benedikt (Author) , Stenzinger, Albrecht (Author) , Fröhling, Stefan (Author) , Keilholz, Ulrich (Author)
Format: Article (Journal)
Language:English
Published: 24 October 2022
In: BMC medicine
Year: 2022, Volume: 20, Pages: 1-11
ISSN:1741-7015
DOI:10.1186/s12916-022-02560-5
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12916-022-02560-5
Verlag, lizenzpflichtig, Volltext: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02560-5
Get full text
Author Notes:Damian T. Rieke, Till de Bortoli, Peter Horak, Mario Lamping, Manuela Benary, Ivan Jelas, Gina Rüter, Johannes Berger, Marit Zettwitz, Niklas Kagelmann, Andreas Kind, Falk Fabian, Dieter Beule, Hanno Glimm, Benedikt Brors, Albrecht Stenzinger, Stefan Fröhling and Ulrich Keilholz
Description
Summary:Structured and harmonized implementation of molecular tumor boards (MTB) for the clinical interpretation of molecular data presents a current challenge for precision oncology. Heterogeneity in the interpretation of molecular data was shown for patients even with a limited number of molecular alterations. Integration of high-dimensional molecular data, including RNA- (RNA-Seq) and whole-exome sequencing (WES), is expected to further complicate clinical application. To analyze challenges for MTB harmonization based on complex molecular datasets, we retrospectively compared clinical interpretation of WES and RNA-Seq data by two independent molecular tumor boards.
Item Description:Gesehen am 10.01.2023
Physical Description:Online Resource
ISSN:1741-7015
DOI:10.1186/s12916-022-02560-5

Similar Items